Blueprint Medicines Announces Pricing of Initial Public Offering
A registration statement relating to these securities has been filed with and was declared effective by the
The offering will be made only by means of a prospectus. A preliminary prospectus describing the terms of the offering has been filed with the
Stern Investor Relations, Inc.
inVentiv Health PR
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/blueprint-medicines-announces-pricing-of-initial-public-offering-300074756.html
SOURCE Blueprint Medicines